The Mount Sinai Hospital
New York, New York 10030
18 studies enrolling now · 77 studies all time
What they study most
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Cancer, Advanced Malignant Neoplasm, Amyloidosis, Immunoglobulin Light-chain, Aneuploidy, Aneurysmal Subarachnoid Hemorrhage (aSAH), Aortic Aneurysm, Aortic Dissection, Aortic Rupture, Aortic Valve Stenosis
Studies at this site
- A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment — Recruiting now
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Recruiting now
- The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). — Recruiting now
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG — Recruiting now
- A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS) — Recruiting now
- ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety) — Recruiting now
- Strategy for Improving Stroke Treatment Response — Recruiting now
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
- REPRESENT-PF Registry — Recruiting now
- A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
- Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease — Recruiting now
- StrokeNet Thrombectomy Endovascular Platform — Recruiting now
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials — Recruiting now
- Pacritinib in CMML — Recruiting now
- Delivering Empowering Conversations About Obstetric Regional Anesthesia for Underserved Minorities — Recruiting now
- AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM — Recruiting now
- TTVR Early Feasibility Study — Running, not enrolling
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
- Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
- ROADSTER 3 Extended Follow-up Sub-Study — Stopped early
- Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
- Ultrafiltration Versus IV Diuretics in Worsening Heart Failure — Stopped early
- Harmony TPV Post-Approval Study — Running, not enrolling
- Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
- First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia — Running, not enrolling
- Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
- Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study — Running, not enrolling
- ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) — Completed
- Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias — Running, not enrolling
- A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
- Optimize PRO Study — Completed
- IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry — Enrolling by invitation
- Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
- IN.PACT™ AV Access Post-Approval Study (PAS002) — Running, not enrolling
- Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease — Completed
- Impact of Intraoperative Cell Salvage — Stopped early
- A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation — Running, not enrolling
- Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers — Running, not enrolling
- Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH — Running, not enrolling
- Viz HCM (ECG Assist) Utilization Workflow Pilot — Completed
- Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency — Completed
- AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection — Completed
- IN.PACT™ AV Access IDE Study — Completed
- A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies — Completed
- Post-resection Treatment of Large Colon Polyps — Completed
- Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation — Completed
- Opioid Use Disorder in the Emergency Department: CTN 0069 — Completed